Literature DB >> 11511530

N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant.

D X Tan1, L C Manchester, S Burkhardt, R M Sainz, J C Mayo, R Kohen, E Shohami, Y S Huo, R Hardeland, R J Reiter.   

Abstract

The biogenic amine The biogenic amine N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) was investigated for its potential antioxidative capacity. AFMK is a metabolite generated through either an enzymatic or a chemical reaction pathway from melatonin. The physiological function of AFMK remains unknown. To our knowledge, this report is the first to document the potent antioxidant action of this biogenic amine. Cyclic voltammetry (CV) shows that AFMK donates two electrons at potentials of 456 mV and 668 mV, and therefore it functions as a reductive force. This function contrasts with all other physiological antioxidants that donate a single electron only when they neutralize free radicals. AFMK reduced 8-hydroxydeoxyguanosine formation induced by the incubation of DNA with oxidants significantly. Lipid peroxidation resulting from free radical damage to rat liver homogenates was also prevented by the addition of AFMK. The inhibitory effects of AFMK on both DNA and lipid damage appear to be dose-response related. In cell culture, AFMK efficiently reduced hippocampal neuronal death induced by either hydrogen peroxide, glutamate, or amyloid b25-35 peptide. AFMK is a naturally occurring molecule with potent free radical scavenging capacity (donating two electrons/molecule) and thus may be a valuable new antioxidant for preventing and treating free radical-related disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511530     DOI: 10.1096/fj.01-0309fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  51 in total

1.  Differential effects of melatonin as a broad range UV-damage preventive dermato-endocrine regulator.

Authors:  Konrad Kleszczyński; Lena H Hardkop; Tobias W Fischer
Journal:  Dermatoendocrinol       Date:  2011-01

Review 2.  Melatonin membrane receptors in peripheral tissues: distribution and functions.

Authors:  Radomir M Slominski; Russel J Reiter; Natalia Schlabritz-Loutsevitch; Rennolds S Ostrom; Andrzej T Slominski
Journal:  Mol Cell Endocrinol       Date:  2012-01-08       Impact factor: 4.102

3.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 4.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 5.  Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Luis C López; Ana B Hitos; Josefa León
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 6.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

7.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

Review 8.  Mitochondrial DNA and inflammatory diseases.

Authors:  Germaine Escames; Luis Carlos López; José Antonio García; Laura García-Corzo; Francisco Ortiz; Darío Acuña-Castroviejo
Journal:  Hum Genet       Date:  2011-07-07       Impact factor: 4.132

9.  Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells.

Authors:  Tae-Kang Kim; Konrad Kleszczynski; Zorica Janjetovic; Trevor Sweatman; Zongtao Lin; Wei Li; Russel J Reiter; Tobias W Fischer; Andrzej T Slominski
Journal:  FASEB J       Date:  2013-04-25       Impact factor: 5.191

10.  Melatonin protects lung mitochondria from aging.

Authors:  Darío Acuña-Castroviejo; Miguel Carretero; Carolina Doerrier; Luis C López; Laura García-Corzo; Jesús A Tresguerres; Germaine Escames
Journal:  Age (Dordr)       Date:  2011-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.